|
231-827-7
|
7757-95-1
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
240-235-8
|
16083-14-0
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
231-111-4
|
7440-02-0
|
Carc. 2; STOT RE 1; Skin Sens. 1
|
|
|
231-111-4
|
7440-02-0
|
Carc. 2; STOT RE 1; Skin Sens. 1
|
|
|
200-193-3
|
54-11-5
|
|
|
|
217-682-2
|
1929-82-4
|
|
|
|
231-714-2
|
7697-37-2
|
Ox. Liq. 2; Acute Tox. 1; Skin Corr. 1A
|
|
|
231-714-2
|
7697-37-2
|
Ox. Liq. 3; Acute Tox. 3; Skin Corr. 1A
|
|
|
238-076-4
|
14216-75-2
|
Ox. Sol. 2; Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1
|
|
DABCO X-412
|
413-670-8
|
103969-79-5
|
Eye Irrit. 2; Skin Sens. 1
|
|
|
202-716-0
|
98-95-3
|
Carc. 2; Repr. 1B; Acute Tox. 3; STOT RE 1
|
|
|
201-188-9
|
79-24-3
|
Flam. Liq. 3; Acute Tox. 4
|
|
|
217-406-0
|
1836-75-5
|
Carc. 1B; Repr. 1B; Acute Tox. 4
|
|
|
233-272-6
|
10102-44-0
|
Press. Gas; Ox. Gas 1; Acute Tox. 2; Skin Corr. 1B
|
|
|
200-876-6
|
75-52-5
|
Flam. Liq. 3; Acute Tox. 4
|
|
|
210-698-0
|
621-64-7
|
|
|
|
-
|
60999-18-0
|
|
|
|
206-400-3
|
335-76-2
|
|
|
|
203-931-2
|
112-05-0
|
Skin Irrit. 2; Eye Irrit. 2
|
|
|
246-672-0
|
25154-52-3
|
Repr. 2; Acute Tox. 4; Skin Corr. 1B
|
|
|
213-589-6
|
991-42-4
|
|
|
|
-
|
2163-79-3
|
|
|
VULKANISATIONSBESCHLEUNIGER VP KA 9124
|
404-380-2
|
110799-28-5
|
|
|
ASIL-322; OS-5200
|
421-870-1
|
156145-66-3
|
Repr. 2; Acute Tox. 4; STOT RE 2
|
|
KENODOX
|
404-300-6
|
116753-76-5
|
|
|
|
221-817-0
|
3244-90-4
|
|
|
|
227-534-9
|
5873-54-1
|
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
|
|
|
202-423-8
|
95-48-7
|
Acute Tox. 3; Skin Corr. 1B
|
|
|
-
|
-
|
|
|
|
218-276-8
|
2104-64-5
|
Acute Tox. 1; Acute Tox. 2
|
|
ETA; ETA 50 (50 %IGE ZUBEREITUNG); O-ETHYLHYDROXYLAMINE
|
402-030-3
|
624-86-2
|
Flam. Liq. 2; Acute Tox. 3; STOT RE 1; Eye Irrit. 2; Skin Sens. 1
|
|
|
432-750-3
|
109202-58-6
|
Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
|
|
|
434-350-4
|
103122-66-3
|
Flam. Liq. 3; Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
|
|
|
201-855-4
|
88-74-4
|
|
|
|
202-430-6
|
95-54-5
|
Carc. 2; Muta. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
|
|
|
210-418-7
|
615-28-1
|
Carc. 2; Muta. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
|
|
|
-
|
-
|
|
|
|
202-429-0
|
95-53-4
|
Carc. 1B; Acute Tox. 3; Eye Irrit. 2
|
|
|
202-422-2
|
95-47-6
|
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2
|
|
|
204-695-3
|
124-30-1
|
Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; Eye Dam. 1
|
|
|
209-136-7
|
556-67-2
|
|
|
|
203-892-1
|
111-65-9
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
|
|
|
204-677-5
|
124-07-2
|
|
|
PROCION BRILLIANT ORANGE H-EXL; S156745
|
412-960-1
|
148878-21-1
|
|
|
H112339
|
413-550-5
|
-
|
Skin Irrit. 2; Eye Dam. 1
|
|
|
247-761-7
|
26530-20-1
|
Acute Tox. 2; Acute Tox. 3; Skin Corr. 1; Eye Dam. 1; Skin Sens. 1A
|
|
|
213-853-0
|
1034-01-1
|
Acute Tox. 4; Skin Sens. 1
|
|
|
-
|
-
|
|
|
An inorganic pigment that is the reaction product of high temperature calcination in which nickel (II) oxide and silicon oxide in varying amounts are homogeneously and ionically interdiffused to form a crystalline matrix of olivine. Its composition may include any one or a combination of the modifiers alkali or alkaline earth halides.
|
271-112-7
|
68515-84-4
|
Carc. 1A; STOT RE 1; Skin Sens. 1
|
|
|
214-197-8
|
1113-02-6
|
Acute Tox. 3; Acute Tox. 4
|
|
|
|
|
|
|